Story
Novo Nordisk Seeks Injunction to Block Eli Lilly's Weight-Loss Drug Ads
Novo Nordisk has escalated its legal dispute with rival Eli Lilly, seeking a preliminary injunction in a U.S. court to immediately block advertisements for Lilly's competing obesity and diabetes drugs.
Legal Action Escalates
The Danish pharmaceutical company announced the move on Friday, according to a Reuters report. The request for an injunction follows a lawsuit Novo Nordisk filed against its U.S. competitor on Tuesday, in which it argued that consumers were being misled by Lilly's advertising about how the companies' products compare.
Novo Nordisk stated earlier in the week that it would seek the preliminary injunction if Eli Lilly did not voluntarily remove the disputed advertisements.
High-Stakes Market Battle
This legal challenge represents the latest development in a fierce rivalry for dominance in the rapidly expanding market for obesity medications. The competition between the two pharmaceutical giants is closely watched by investors as they vie for market share.
AdAnalysts project the market for these drugs could be worth more than $100 billion in the United States alone by the end of the decade, making advertising and market positioning critical strategic priorities for both firms.
Company Positions
In response to the initial lawsuit on Tuesday, Eli Lilly denied any wrongdoing, stated that it stood by its advertising, and intended to "vigorously defend itself" against the claims.
The U.S.-based drugmaker did not immediately respond to a request for comment regarding the new injunction filing on Friday, Reuters reported.
Read next
More on Stocks
FTC Orders Walmart, Uber, Delta to Disclose Data on Personalized Pricing
The U.S. Federal Trade Commission is demanding nine major companies, including leading retail, travel, and gig economy firms, to provide information on how they use consumer data for setting individual prices and wages.
Google Launches Gemini 4 Carbon AI Model to Bolster Cybersecurity Capabilities
Alphabet's Google has unveiled Gemini 4 Carbon, its latest AI model specifically designed for advanced cybersecurity tasks like vulnerability detection and secure code generation. The launch escalates competition with rivals OpenAI and Anthropic in the enterprise AI market.
Oracle Shares Surge After Unveiling $225 Billion Revenue Target for 2030
Oracle stock rose sharply after the company presented a long-term financial outlook targeting at least $225 billion in annual revenue by fiscal 2030, driven by its expanding AI infrastructure business.
DOJ Scrutinizes Nvidia's $12.9B Hugging Face Deal Amid Broader Antitrust Probe, Sources Say
The U.S. Department of Justice is reportedly examining Nvidia's planned $12.93 billion acquisition of AI platform Hugging Face as part of a wider, ongoing antitrust investigation into the chipmaker's market conduct.